Clinical characteristics of LVAD patients at the time of bloodstream infection episodes, stratified by fever status
| Characteristics | Afebrile at time of culture n=52 | Febrile at time of culture n=7 | P values |
| Age at BSI, years | 60±13 | 59±8 | 0.42 |
| Duration from time from LVAD implantation to BSI, days | 299 (147, 624) | 587 (285, 628) | 0.31 |
| HeartMate II LVAD | 32 (62) | 6 (86) | 0.43 |
| White cell count, ×109 cells/L at time of culture | 9.8 (6.8, 14.0) | 8.9 (7.1, 16.1) | 0.65 |
| MAP, mm Hg at time of culture | 73 (63, 87) | 76 (64, 78) | 0.33 |
| BMI, kg/m2 | 27.4 (22.8, 31.8) | 32.5 (23.1, 37.7) | 0.12 |
| Aspirin therapy | 43 (83) | 4 (57) | 0.20 |
| Aspirin dose 325 mg (vs 81 mg) | 26 (62) | 3 (75) | 0.67 |
| Outpatient acetaminophen prescription | 12 (23) | 2 (29) | 1.0 |
Data are presented in mean±SD, median (25th, 75th percentile) or count (%).
BMI, body mass index; BSI, bloodstream infection; LVAD, left ventricular assist device; MAP, mean arterial pressure.